The Ensign Group, Inc. (ENSG)
NASDAQ: ENSG · IEX Real-Time Price · USD
125.93
+1.79 (1.44%)
At close: Jul 2, 2024, 4:00 PM
126.25
+0.32 (0.25%)
After-hours: Jul 2, 2024, 7:51 PM EDT

The Ensign Group Revenue

The Ensign Group had revenue of $3.85B in the twelve months ending March 31, 2024, with 20.44% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.01B with 13.91% year-over-year growth. In the year 2023, The Ensign Group had annual revenue of $3.73B with 23.27% growth.

Revenue (ttm)
$3.85B
Revenue Growth
+20.44%
P/S Ratio
1.86
Revenue / Employee
$109,141
Employees
35,300
Market Cap
7.17B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.73B703.89M23.27%
Dec 31, 20223.03B398.01M15.15%
Dec 31, 20212.63B224.87M9.36%
Dec 31, 20202.40B366.07M17.98%
Dec 31, 20192.04B281.92M16.07%
Dec 31, 20181.75B156.28M9.78%
Dec 31, 20171.60B-56.54M-3.42%
Dec 31, 20161.65B313.04M23.33%
Dec 31, 20151.34B314.42M30.60%
Dec 31, 20141.03B122.85M13.58%
Dec 31, 2013904.56M81.40M9.89%
Dec 31, 2012823.16M64.88M8.56%
Dec 31, 2011758.28M108.75M16.74%
Dec 31, 2010649.53M107.53M19.84%
Dec 31, 2009542.00M72.63M15.47%
Dec 31, 2008469.37M58.05M14.11%
Dec 31, 2007411.32M52.74M14.71%
Dec 31, 2006358.57M57.72M19.19%
Dec 31, 2005300.85M56.31M23.03%
Dec 31, 2004244.54M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Elanco Animal Health 4.37B
Bio-Rad Laboratories 2.61B
Penumbra 1.10B
HealthEquity 1.04B
Ionis Pharmaceuticals 776.62M
Repligen 607.45M
Intra-Cellular Therapies 513.93M
Ascendis Pharma 357.63M
Revenue Rankings